title: A novel effective therapy for refractory angiosarcoma of the face and scalp.
authors.affiliation: Department of Medical Oncology, Providence Regional Cancer Partnership, Everett, WA, USA. pjiang2009@gmail.com
authors.forename: Peter Yz
authors.initials: PY
authors.lastname: Jiang
authors.forename: Renee
authors.initials: R
authors.lastname: Yanke
authors.forename: David
authors.initials: D
authors.lastname: Kantorowitz
mesh_terms: D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005145:Face / Q000473:pathology; D005260:Female; D006394:Hemangiosarcoma / Q000188:drug therapy*; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage*; D017239:Paclitaxel / Q000627:therapeutic use; D011878:Radiotherapy; D016879:Salvage Therapy / Q000379:methods*; D012535:Scalp / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy*; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D004317:Doxorubicin; D003520:Cyclophosphamide; D017239:Paclitaxel; D008727:Methotrexate; D000093542:Gemcitabine